These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 9754559

  • 1. Involvement of APO2 ligand/TRAIL in activation-induced death of Jurkat and human peripheral blood T cells.
    Martínez-Lorenzo MJ, Alava MA, Gamen S, Kim KJ, Chuntharapai A, Piñeiro A, Naval J, Anel A.
    Eur J Immunol; 1998 Sep; 28(9):2714-25. PubMed ID: 9754559
    [Abstract] [Full Text] [Related]

  • 2. CD59 cross-linking induces secretion of APO2 ligand in overactivated human T cells.
    Monleón I, Martínez-Lorenzo MJ, Anel A, Lasierra P, Larrad L, Piñeiro A, Naval J, Alava MA.
    Eur J Immunol; 2000 Apr; 30(4):1078-87. PubMed ID: 10760796
    [Abstract] [Full Text] [Related]

  • 3. Differential secretion of Fas ligand- or APO2 ligand/TNF-related apoptosis-inducing ligand-carrying microvesicles during activation-induced death of human T cells.
    Monleón I, Martínez-Lorenzo MJ, Monteagudo L, Lasierra P, Taulés M, Iturralde M, Piñeiro A, Larrad L, Alava MA, Naval J, Anel A.
    J Immunol; 2001 Dec 15; 167(12):6736-44. PubMed ID: 11739488
    [Abstract] [Full Text] [Related]

  • 4. Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles.
    Martínez-Lorenzo MJ, Anel A, Gamen S, Monle n I, Lasierra P, Larrad L, Piñeiro A, Alava MA, Naval J.
    J Immunol; 1999 Aug 01; 163(3):1274-81. PubMed ID: 10415024
    [Abstract] [Full Text] [Related]

  • 5. Down-regulation of normal human T cell blast activation: roles of APO2L/TRAIL, FasL, and c- FLIP, Bim, or Bcl-x isoform expression.
    Bosque A, Pardo J, Martínez-Lorenzo MJ, Iturralde M, Marzo I, Piñeiro A, Alava MA, Naval J, Anel A.
    J Leukoc Biol; 2005 Apr 01; 77(4):568-78. PubMed ID: 15653751
    [Abstract] [Full Text] [Related]

  • 6. Apo2 ligand/TNF-related apoptosis-inducing ligand and death receptor 5 mediate the apoptotic signaling induced by ionizing radiation in leukemic cells.
    Gong B, Almasan A.
    Cancer Res; 2000 Oct 15; 60(20):5754-60. PubMed ID: 11059770
    [Abstract] [Full Text] [Related]

  • 7. Release of preformed Fas ligand in soluble form is the major factor for activation-induced death of Jurkat T cells.
    Martínez-Lorenzo MJ, Alava MA, Anel A, Piñeiro A, Naval J.
    Immunology; 1996 Dec 15; 89(4):511-7. PubMed ID: 9014814
    [Abstract] [Full Text] [Related]

  • 8. FADD deficiency sensitises Jurkat T cells to TNF-alpha-dependent necrosis during activation-induced cell death.
    Lawrence CP, Chow SC.
    FEBS Lett; 2005 Nov 21; 579(28):6465-72. PubMed ID: 16289096
    [Abstract] [Full Text] [Related]

  • 9. The human melanoma cell line MelJuSo secretes bioactive FasL and APO2L/TRAIL on the surface of microvesicles. Possible contribution to tumor counterattack.
    Martínez-Lorenzo MJ, Anel A, Alava MA, Piñeiro A, Naval J, Lasierra P, Larrad L.
    Exp Cell Res; 2004 May 01; 295(2):315-29. PubMed ID: 15093732
    [Abstract] [Full Text] [Related]

  • 10. TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in Fas ligand-resistant melanoma cells and mediates CD4 T cell killing of target cells.
    Thomas WD, Hersey P.
    J Immunol; 1998 Sep 01; 161(5):2195-200. PubMed ID: 9725211
    [Abstract] [Full Text] [Related]

  • 11. Interleukin-1 beta converting enzyme-like protease involvement in Fas-induced and activation-induced peripheral blood T cell apoptosis in HIV infection. TNF-related apoptosis-inducing ligand can mediate activation-induced T cell death in HIV infection.
    Katsikis PD, Garcia-Ojeda ME, Torres-Roca JF, Tijoe IM, Smith CA, Herzenberg LA, Herzenberg LA.
    J Exp Med; 1997 Oct 20; 186(8):1365-72. PubMed ID: 9334376
    [Abstract] [Full Text] [Related]

  • 12. Interleukin-6 (IL-6) prevents activation-induced cell death: IL-2-independent inhibition of Fas/fasL expression and cell death.
    Ayroldi E, Zollo O, Cannarile L, D' Adamio F, Grohmann U, Delfino DV, Riccardi C.
    Blood; 1998 Dec 01; 92(11):4212-9. PubMed ID: 9834226
    [Abstract] [Full Text] [Related]

  • 13. Molecular and cellular mechanisms regulating T and B cell apoptosis through Fas/FasL interaction.
    Ju ST, Matsui K, Ozdemirli M.
    Int Rev Immunol; 1999 Dec 01; 18(5-6):485-513. PubMed ID: 10672498
    [Abstract] [Full Text] [Related]

  • 14. Human CD8+ T cell blasts are more sensitive than CD4+ T cell blasts to regulation by APO2L/TRAIL.
    Bosque A, Pardo J, Martínez-Lorenzo MJ, Lasierra P, Larrad L, Marzo I, Naval J, Anel A.
    Eur J Immunol; 2005 Jun 01; 35(6):1812-21. PubMed ID: 15884050
    [Abstract] [Full Text] [Related]

  • 15. Cell cycle regulation by FasL and Apo2L/TRAIL in human T-cell blasts. Implications for autoimmune lymphoproliferative syndromes.
    Bosque A, Aguiló JI, del Rey M, Paz-Artal E, Allende LM, Naval J, Anel A.
    J Leukoc Biol; 2008 Aug 01; 84(2):488-98. PubMed ID: 18483205
    [Abstract] [Full Text] [Related]

  • 16. Resistance to Apo2 ligand (Apo2L)/tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis and constitutive expression of Apo2L/TRAIL in human T-cell leukemia virus type 1-infected T-cell lines.
    Matsuda T, Almasan A, Tomita M, Uchihara JN, Masuda M, Ohshiro K, Takasu N, Yagita H, Ohta T, Mori N.
    J Virol; 2005 Feb 01; 79(3):1367-78. PubMed ID: 15650163
    [Abstract] [Full Text] [Related]

  • 17. Involvement of TNF-related apoptosis-inducing ligand in human CD4+ T cell-mediated cytotoxicity.
    Kayagaki N, Yamaguchi N, Nakayama M, Kawasaki A, Akiba H, Okumura K, Yagita H.
    J Immunol; 1999 Mar 01; 162(5):2639-47. PubMed ID: 10072506
    [Abstract] [Full Text] [Related]

  • 18. Regulation of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in thyroid carcinoma cells.
    Poulaki V, Mitsiades CS, Kotoula V, Tseleni-Balafouta S, Ashkenazi A, Koutras DA, Mitsiades N.
    Am J Pathol; 2002 Aug 01; 161(2):643-54. PubMed ID: 12163389
    [Abstract] [Full Text] [Related]

  • 19. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
    Brando C, Mukhopadhyay S, Kovacs E, Medina R, Patel P, Catina TL, Campbell KS, Santoli D.
    J Leukoc Biol; 2005 Aug 01; 78(2):359-71. PubMed ID: 15937142
    [Abstract] [Full Text] [Related]

  • 20. Alpha-fetoprotein triggers hepatoma cells escaping from immune surveillance through altering the expression of Fas/FasL and tumor necrosis factor related apoptosis-inducing ligand and its receptor of lymphocytes and liver cancer cells.
    Li MS, Ma QL, Chen Q, Liu XH, Li PF, Du GG, Li G.
    World J Gastroenterol; 2005 May 07; 11(17):2564-9. PubMed ID: 15849812
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.